24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY AFFINITY MATURATION |
45.31% |
|
ALZHEIMERS |
37.5% |
|
ENZYME DYNAMICS |
17.19% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
26.04% |
|
ANTIBODY DYNAMICS |
21.23% |
|
ENZYME DYNAMICS |
14.88% |
|
UNSPECIFIED |
9.85% |
|
ANTIBODY DYNAMICS SIMULATION |
9.19% |
|
IL 2 RECEPTOR DYNAMICS |
8.1% |
|
ANTIBODY AFFINITY MATURATION |
6.35% |
|
IL 2 FORCE FIELD BENCHMARKING |
4.38% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
30.67% |
|
ANTIBODY DYNAMICS |
15.18% |
|
ENZYME DYNAMICS |
14.08% |
|
ANTIBODY DYNAMICS SIMULATION |
13.3% |
|
UNSPECIFIED |
7.04% |
|
IL 2 DYNAMICS SIMULATIONS |
6.26% |
|
IL 2 RECEPTOR DYNAMICS |
5.79% |
|
ANTIBODY AFFINITY MATURATION |
4.54% |
|
IL 2 FORCE FIELD BENCHMARKING |
3.13% |